MULLER, Elmi; BARDAY, Zunaid; MENDELSON, Marc
and
KAHN, Delawir. Renal transplantation between HIV-positive donors and recipients justified. SAMJ, S. Afr. med. j. [online].
2012,
vol.102, n.6, pp. 497-498.
ISSN 0256-9574.
|
|
2. Han TM, Naicker S, Ramdial PK, Assounga AG. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney Int 2006;69(12):2243-2250. [ Links ] 3. Winston J, Klotman PE. HIV-associated nephropathy. Mt Sinai J Med 1998;65(1):27-32. [ Links ] 4. Fabian J, Katz T, Gerntholtz T. Chronic kidney disease in HIV infection. Panminerva Med 2007;49(2):51-66. [ Links ] 5. Wools-Kaloustian KK, Gupt SK. Will there be an epidemic of HIV-related chronic kidney disease in Sub-Saharan Africa? Too soon to tell. Kidney Int 2008;74(7):925-929. [ Links ] 6. Moosa MR, Kidd M. The dangers of rationing dialysis treatment: the dilemma facing a developing country. Kidney Int 2006;70:1107-1114. [ Links ] 7. Halpern SD, Asch DA, Shaked A, et al. Determinants of transplant surgeons' willingness to provide organs to patients infected with HBV, HCV or HIV. Am J Transplant 2005;5(6):1319-1325. [ Links ] 8. Pelletier SJ, Norman SP, Christensen LL, et al. Review of transplantation in HIV patients during the HAART era. Clin Transpl 2004:63-82. [ Links ] 9. Roland ME, Barin B, Carlson L, et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant 2008;8(2):355-365. [ Links ] 10. Roland ME, Stock PG. Solid organ transplantation is a reality for patients with HIV infection. Curr HIV/AIDS Rep 2006;3(3):132-138. [ Links ] 11. Stock PG, Barin B, Murphy B, et al. Outcomes of kidney transplantation in HIV-infected recipients. N Engl J Med 2010;363(21):2004-2014. [ Links ] 12. Frasesetto LA, Browne M, Cheng A, et al. Immunosuppressant pharmacokinetics and dosing modifications in HIV-1 infected liver and kidney transplant recipients. Am J Transplant 2007;7(12):2816-2820. [ Links ] 13. Frasetto L, Baluom M, Jacobsen W, et al. Cyclosporin pharmacokinetics and dosing modifications in human immunodeficiency virus-infected liver and kidney transplant recipients. Transplantation 2005;80(1):13-17. [ Links ] 14. Ciuffreda D, Pantaleo G, Pascuel M. Effects of immunosuppressive drugs on HIV infection: implications for solid-organ transplantation. Transpl Int 2007;20:649-658. [ Links ] 15. Rizzardi GP, Harari A, Capiluppi B, et al. Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy. J Clin Invest 2002;109:681-688. [ Links ] 16. Margolis D, Heredia A, Oldach D, et al. Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergystic anti-HIV activity. J Acquir Immune Defic Syndr 1999;21:362-370. [ Links ] 17. Streeck H, Li B, Poon AF, et al. Immune driven recombination and loss of control after HIV superinfection. J Exp Med 2008; 205(8):1789-1796. [ Links ] 18. Van Der Kuyl A, Cornelissen M. Identifying HIV-1 dual infections. Retrovirology 2007,4:67-672. [ Links ] 19. Goulder P, Walker B. HIV-1 superinfection - a word of caution. N Engl J Med 2002;347(10):756-758. [ Links ] 20. Muller E, Kahn D, Mendelson M. Renal transplantation between HIV-positive donors and recipients. N Engl J Med 2010;362(24):2337. [ Links ] |
